Skip to main content
Log in

Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats

  • Letter to the Editor
  • Published:
Obesity Surgery Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Younossi ZM, Page S, Rafiq N, et al. A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes Surg. 2011;21:431–9.

    Article  PubMed  Google Scholar 

  2. Yilmaz Y, Ulukaya E. Toward a biochemical diagnosis of NASH: insights from pathophysiology for distinguishing simple steatosis from steatohepatitis. Curr Med Chem. 2011;18:725–32.

    Article  PubMed  CAS  Google Scholar 

  3. Yilmaz Y, Kedrah AE, Ozdogan O. Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis. World J Gastroenterol. 2009;15:4387–91.

    Article  PubMed  CAS  Google Scholar 

  4. Muzzillo DA, Imoto M, Fukuda Y, et al. Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gastroenterol Hepatol. 1993;8:437–41.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuf Yilmaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yilmaz, Y., Kurt, R. & Eren, F. Multimarker Strategies for Detecting NASH and NASH-Related Fibrosis: Promises and Caveats. OBES SURG 21, 1316–1317 (2011). https://doi.org/10.1007/s11695-011-0464-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-011-0464-4

Keywords

Navigation